Harbour BioMed (the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of ...
SAN DIEGO--(BUSINESS WIRE)--BioMed Realty (“Company”), a leading provider of real estate solutions to the life science and technology industries, today provided highlights of its continued 2024 ...
SAN DIEGO--(BUSINESS WIRE)--BioMed Realty (“Company”), a leading provider of real estate solutions to the life science and technology industries, today provided highlights of its continued 2023 ...
Orchestra BioMed has announced that the FDA has granted Breakthrough Device Designation for its atrioventricular interval modulation (AVIM) therapy, aimed at treating over 7.7 million U.S. patients ...
BioMed Realty Trust continues to push the life sciences conversion wave in Boston, quietly taking over two prominent development sites. The Blackstone-backed life sciences investor has entered a ...
One of the biggest real estate investors in the world just made a deal that reinforces how the life sciences industry has been supercharged by the coronavirus pandemic. The internal transaction is the ...
Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) (“Orchestra BioMed” or the “Company”), a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results